|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Non-cash operating lease expense | |||||
| Interest expense on related party note payable | |||||
| Change in inventory reserve | |||||
| Impairment of intangible assets | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Deposits and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Payments for patent licenses | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Principal repayment on note payable from related party | |||||
| Net cash used in financing activities | |||||
| Net decrease in cash | |||||
| Cash, beginning of period | |||||
| Cash, end of period | |||||
| Supplemental disclosure of non-cash operating activities: | |||||
| Operating lease right-of-use asset obtained in exchange for operating lease liabilities | |||||
| Supplemental disclosure of non-cash investing activities: | |||||
| Patent license costs included in accounts payable and accrued expense | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
Loading...